Astera Labs revenue and financials
In the fiscal year ended December 2025, Astera Labs reported revenue of $852.53M (+115.13% year over year). Net income was $219.13M, a net margin of 25.7%.
Fiscal year ending in December. Sources and method on the page How we analyse stocks.
At a glance
- Revenue growth
- +115.13%
- 2025 vs 2024
- Net margin
- 25.7%
- 2024: -21.1%
How Astera Labs is changing
Calculated from the annual statements; each fiscal year is labelled with the year it ends.
Revenue grew 120.2% a year on average over the last 3 years
Compound annual growth rate: from $79.87M in 2022 to $852.53M in 2025.
Revenue has grown for 3 fiscal years in a row
Each fiscal year compared with the one before, up to 2025.
Operating margin rose from −75.4% to 20.3%
Operating income over revenue, 2022 → 2025: 95.7 percentage points.
Shares outstanding up 425.4% in 3 years
Average diluted shares, 2022 → 2025: with more shares, each one represents a smaller stake in the company (dilution).
Profitable in 1 of 4 fiscal years
Positive net income, fiscal years 2022–2025.
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | 853 | 396 | 116 | 79.9 |
| Cost of revenue | 207 | 93.6 | 36.0 | 21.2 |
| Gross profit | 645 | 303 | 79.8 | 58.7 |
| Selling, general and administrative | 168 | 218 | 35.9 | 45.2 |
| Research and development | 304 | 201 | 73.4 | 73.7 |
| Operating income | 173 | -116 | -29.5 | -60.2 |
| EBIT | 173 | -116 | -29.5 | -60.2 |
| EBITDA | 180 | -113 | -27.7 | -59.4 |
| Pre-tax income | 218 | -81.8 | -22.9 | -57.6 |
| Income tax | -1.0 | 1.6 | 3.3 | 0.8 |
| Net income | 219 | -83.4 | -26.3 | -58.3 |
| Net income to common shareholders | 219 | -83.4 | -26.3 | -58.3 |
| Basic EPS | 1.32 | -0.64 | -0.71 | -1.71 |
| Diluted EPS | 1.22 | -0.64 | -0.71 | -1.71 |
| Average shares (basic) | 166 | 131 | 37.1 | 34.2 |
| Average shares (diluted) | 180 | 131 | 37.1 | 34.2 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 585 | 392 | 308 | 271 | 231 | 192 | 159 | 141 | 113 | 76.9 | 65.3 | 50.5 |
| Cost of revenue | 162 | 105 | 73.2 | 66.1 | 54.8 | 46.4 | 40.0 | 36.6 | 25.2 | 17.0 | 14.7 | 11.5 |
| Gross profit | 423 | 288 | 235 | 204 | 176 | 146 | 119 | 104 | 87.9 | 59.9 | 50.5 | 39.0 |
| Selling, general and administrative | 72.7 | 62.4 | 47.7 | 43.7 | 41.5 | 39.1 | 43.6 | 47.8 | 46.1 | 44.1 | 79.9 | 10.4 |
| Research and development | 171 | 136 | 126 | 93.8 | 78.9 | 66.7 | 64.6 | 56.5 | 50.7 | 40.1 | 53.6 | 19.7 |
| Operating income | 179 | 89.2 | 61.8 | 67.0 | 55.4 | 39.8 | 11.3 | 0.1 | -8.9 | -24.3 | -83.0 | 9.0 |
| EBIT | 179 | 89.2 | 61.8 | 67.0 | 55.4 | 39.8 | 11.3 | 0.1 | -8.9 | -24.3 | -83.0 | 9.0 |
| EBITDA | 184 | 93.2 | 65.5 | 69.8 | 56.9 | 41.2 | 12.4 | 1.1 | -8.0 | -23.6 | -82.4 | 9.6 |
| Pre-tax income | 192 | 103 | 73.4 | 78.9 | 66.9 | 50.7 | 21.7 | 10.7 | 2.0 | -14.1 | -80.4 | 10.7 |
| Income tax | 9.1 | -50.3 | -6.9 | 33.9 | -24.3 | -0.6 | -10.1 | -14.0 | 9.6 | -6.5 | 12.6 | -3.6 |
| Net income | 183 | 153 | 80.3 | 45.0 | 91.1 | 51.2 | 31.8 | 24.7 | -7.6 | -7.5 | -93.0 | 14.3 |
| Net income to common shareholders | 183 | 153 | 80.3 | 45.0 | 91.1 | 51.2 | 31.8 | 24.7 | -7.6 | -7.5 | -93.0 | 14.3 |
| Basic EPS | 1.05 | 0.89 | 0.47 | 0.27 | 0.54 | 0.31 | 0.19 | 0.15 | -0.05 | -0.05 | -1.77 | 0.37 |
| Diluted EPS | 0.99 | 0.83 | 0.44 | 0.25 | 0.50 | 0.29 | 0.18 | 0.14 | -0.05 | -0.05 | -1.77 | 0.37 |
| Average shares (basic) | 174 | 172 | 171 | 170 | 167 | 165 | 163 | 160 | 157 | 155 | 52.5 | 38.6 |
| Average shares (diluted) | 184 | 183 | 181 | 181 | 181 | 178 | 178 | 178 | 157 | 155 | 52.5 | 38.6 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total assets | 1,532 | 1,055 | 196 | 212 |
| Current assets | 1,362 | 1,013 | 186 | 206 |
| Cash and equivalents | 168 | 79.6 | 45.1 | 76.1 |
| Short-term investments | 1,021 | 835 | 104 | 87.1 |
| Receivables | 83.2 | 38.8 | 8.3 | 10.7 |
| Inventory | 59.0 | 43.2 | 24.1 | 28.9 |
| Net property, plant and equipment | 115 | 38.6 | 7.6 | 3.5 |
| Current liabilities | 133 | 86.5 | 35.1 | 40.1 |
| Accounts payable | 42.4 | 26.9 | 6.3 | 10.3 |
| Total debt | 31.0 | 3.1 | 2.9 | 2.0 |
| Total liabilities | 168 | 89.7 | 38.9 | 41.9 |
| Total equity (incl. minority) | 1,364 | 965 | 157 | 170 |
| Retained earnings | 10.3 | -209 | -125 | -99.1 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2,300 | 1,932 | 1,659 | 1,532 | 1,401 | 1,271 | 1,122 | 1,055 | 983 | 916 | 865 | 196 |
| Current assets | 1,955 | 1,652 | 1,413 | 1,362 | 1,290 | 1,181 | 1,076 | 1,013 | 946 | 891 | 854 | 186 |
| Cash and equivalents | 209 | 111 | 148 | 168 | 140 | 162 | 86.4 | 79.6 | 126 | 421 | 696 | 45.1 |
| Short-term investments | 1,169 | 1,142 | 1,036 | 1,021 | 994 | 903 | 838 | 835 | 761 | 410 | 105 | 104 |
| Receivables | 284 | 253 | 135 | 83.2 | 42.9 | 24.3 | 69.8 | 38.8 | 25.4 | 22.2 | 16.8 | 8.3 |
| Inventory | 201 | 114 | 60.2 | 59.0 | 51.7 | 58.6 | 51.1 | 43.2 | 24.4 | 28.6 | 29.6 | 24.1 |
| Net property, plant and equipment | 171 | 155 | 131 | 115 | 94.7 | 84.7 | 39.5 | 38.6 | 35.1 | 21.8 | 7.6 | 7.6 |
| Goodwill | 91.6 | 91.6 | 87.7 | — | — | — | — | — | — | — | — | — |
| Current liabilities | 244 | 164 | 125 | 133 | 101 | 106 | 77.3 | 86.5 | 88.0 | 64.1 | 45.6 | 35.1 |
| Accounts payable | 96.8 | 53.9 | 55.8 | 42.4 | 25.8 | 31.6 | 29.5 | 26.9 | 18.6 | 14.6 | 11.5 | 6.3 |
| Total debt | — | 44.4 | 41.9 | 31.0 | 31.3 | 32.3 | — | 3.1 | — | 2.1 | 2.3 | — |
| Total liabilities | 301 | 206 | 165 | 168 | 129 | 136 | 80.1 | 89.7 | 93.5 | 70.3 | 56.1 | 38.9 |
| Total equity (incl. minority) | 1,999 | 1,726 | 1,494 | 1,364 | 1,272 | 1,136 | 1,042 | 965 | 890 | 845 | 809 | 157 |
| Retained earnings | 427 | 244 | 90.6 | 10.3 | -34.6 | -126 | -177 | -209 | -234 | -226 | -218 | -125 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating cash flow | 319 | 137 | -12.7 | -35.9 |
| Depreciation and amortization | 6.8 | 3.2 | 1.8 | 0.8 |
| Capital expenditure | -37.5 | -34.2 | -2.8 | -3.9 |
| Investing cash flow | -241 | -758 | -17.8 | -90.6 |
| Financing cash flow | 9.8 | 656 | -0.5 | 152 |
| Share repurchases | 0.0 | -21.2 | -0.2 | -0.3 |
| Net change in cash | 87.6 | 34.9 | -31.0 | 25.2 |
| Free cash flow | 282 | 102 | -15.5 | -39.8 |
| Levered free cash flow | 207 | 121 | -7.9 | — |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 179 | 87.7 | 74.6 | 95.3 | 78.2 | 135 | 10.5 | 39.7 | 63.5 | 29.8 | 3.7 | 14.4 |
| Depreciation and amortization | 5.0 | 3.9 | 3.7 | 2.8 | 1.5 | 1.4 | 1.1 | 1.0 | 0.8 | 0.7 | 0.6 | 0.5 |
| Capital expenditure | -45.3 | -20.5 | -7.6 | -18.7 | -12.3 | -2.0 | -4.5 | -15.4 | -16.7 | 1.3 | -3.4 | -1.0 |
| Investing cash flow | -81.2 | -132 | -94.0 | -72.8 | -101 | -63.7 | -3.9 | -91.4 | -359 | -302 | -4.3 | -6.0 |
| Financing cash flow | -0.0 | 7.0 | 0.1 | 3.7 | 1.0 | 4.7 | 0.4 | 5.7 | 1.0 | -2.3 | 652 | -1.1 |
| Share repurchases | -0.0 | — | — | — | — | — | — | -1.1 | 0.0 | 0.0 | -20.1 | -0.2 |
| Net change in cash | 97.9 | -36.8 | -19.3 | 26.2 | -21.9 | 76.4 | 7.0 | -46.1 | -295 | -275 | 651 | 7.4 |
| Free cash flow | 134 | 67.2 | 67.0 | 76.6 | 65.9 | 133 | 6.0 | 24.3 | 46.8 | 31.1 | 0.2 | 13.4 |
| Levered free cash flow | 61.7 | -28.5 | 18.9 | 82.3 | 19.3 | 120 | -14.3 | -8.8 | 51.7 | 41.4 | 36.9 | — |
Financial statements of similar companies
Companies in the group: same industry, similar size
